Put Options

7 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2024

Aug 05, 2024

SELL
$724.87 - $909.04 $1.01 Million - $1.27 Million
-1,400 Reduced 20.59%
5,400 $4.89 Million
Q1 2024

May 08, 2024

SELL
$592.2 - $792.28 $296,100 - $396,140
-500 Reduced 6.85%
6,800 $5.29 Million
Q4 2023

Feb 02, 2024

BUY
$525.19 - $619.13 $420,152 - $495,304
800 Added 12.31%
7,300 $4.26 Million
Q3 2023

Oct 26, 2023

BUY
$434.7 - $599.3 $1.43 Million - $1.98 Million
3,300 Added 103.13%
6,500 $3.49 Million
Q2 2023

Aug 08, 2023

SELL
$350.74 - $468.98 $3.96 Million - $5.3 Million
-11,300 Reduced 77.93%
3,200 $1.5 Million
Q1 2023

May 02, 2023

BUY
$310.63 - $364.82 $3.85 Million - $4.52 Million
12,400 Added 590.48%
14,500 $4.98 Million
Q4 2022

Jan 23, 2023

BUY
$321.55 - $374.67 $675,255 - $786,807
2,100 New
2,100 $0

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $778B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Xr Securities LLC Portfolio

Follow Xr Securities LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Xr Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Xr Securities LLC with notifications on news.